92 related articles for article (PubMed ID: 8064664)
1. Unexpected neurotoxicity in dogs receiving a cyclophosphamide, dactinomycin, and 5-fluorouracil chemotherapy protocol.
Hammer AS; Carothers MA; Harris CL; O'Keefe DA; Ayl RD; Peterson JL; Shank KA; Couto CG
J Vet Intern Med; 1994; 8(3):240-3. PubMed ID: 8064664
[TBL] [Abstract][Full Text] [Related]
2. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
Hammer AS; Couto CG; Filppi J; Getzy D; Shank K
J Vet Intern Med; 1991; 5(3):160-6. PubMed ID: 1920253
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of dogs with advanced primary lung carcinoma treated by metronomic cyclophosphamide, piroxicam and thalidomide.
Polton G; Finotello R; Sabattini S; Rossi F; Laganga P; Vasconi ME; Barbanera A; Stiborova K; Rohrer Bley C; Marconato L
Vet Comp Oncol; 2018 Sep; 16(3):399-408. PubMed ID: 29508493
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant post-operative chemotherapy in bitches with mammary cancer.
Karayannopoulou M; Kaldrymidou E; Constantinidis TC; Dessiris A
J Vet Med A Physiol Pathol Clin Med; 2001 Mar; 48(2):85-96. PubMed ID: 11315572
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of an actinomycin-D-containing combination chemotherapy protocol with extended maintenance therapy for canine lymphoma.
Siedlecki CT; Kass PH; Jakubiak MJ; Dank G; Lyons J; Kent MS
Can Vet J; 2006 Jan; 47(1):52-9. PubMed ID: 16536229
[TBL] [Abstract][Full Text] [Related]
7. VAC protocol for treatment of dogs with stage III hemangiosarcoma.
Alvarez FJ; Hosoya K; Lara-Garcia A; Kisseberth W; Couto G
J Am Anim Hosp Assoc; 2013; 49(6):370-7. PubMed ID: 24051260
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and toxicity of doxorubicin/cyclophosphamide maintenance therapy in dogs with multicentric lymphosarcoma.
Price GS; Page RL; Fischer BM; Levine JF; Gerig TM
J Vet Intern Med; 1991; 5(5):259-62. PubMed ID: 1748977
[TBL] [Abstract][Full Text] [Related]
9. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma.
Zemann BI; Moore AS; Rand WM; Mason G; Ruslander DM; Frimberger AE; Wood CA; L'Heureux DA; Gliatto J; Cotter SM
J Vet Intern Med; 1998; 12(6):465-70. PubMed ID: 9857340
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of toxicity of a chronic alternate day metronomic cyclophosphamide chemotherapy protocol in dogs with naturally occurring cancer.
Matsuyama A; Woods JP; Mutsaers AJ
Can Vet J; 2017 Jan; 58(1):51-55. PubMed ID: 28042155
[TBL] [Abstract][Full Text] [Related]
11. Mitoxantrone, 5-fluorouracil, and high dose leucovorin (NFL) versus intravenous cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in first-line chemotherapy for patients with metastatic breast carcinoma: a randomized phase II trial.
Hainsworth JD; Jolivet J; Birch R; Hopkins LG; Greco FA
Cancer; 1997 Feb; 79(4):740-8. PubMed ID: 9024712
[TBL] [Abstract][Full Text] [Related]
12. Mitoxantrone and cyclophosphamide combination chemotherapy for the treatment of various canine malignancies.
Henry CJ; Buss MS; Potter KA; Wardrop KJ
J Am Anim Hosp Assoc; 1999; 35(3):236-9. PubMed ID: 10333263
[TBL] [Abstract][Full Text] [Related]
13. Phase I lead-in and subsequent randomized trial assessing safety and modulation of regulatory T cell numbers following a maximally tolerated dose doxorubicin and metronomic dose cyclophosphamide combination chemotherapy protocol in tumour-bearing dogs.
Rasmussen RM; Kurzman ID; Biller BJ; Guth A; Vail DM
Vet Comp Oncol; 2017 Jun; 15(2):421-430. PubMed ID: 26522053
[TBL] [Abstract][Full Text] [Related]
14. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of combination chemotherapy with dexamethasone for lymphoma in dogs.
Greenberg CB; Boria PA; Borgatti-Jeffreys A; Raskin RE; Lucroy MD
J Am Anim Hosp Assoc; 2007; 43(1):27-32. PubMed ID: 17209082
[TBL] [Abstract][Full Text] [Related]
16. Hematological toxicity of doxorubicin-containing protocols in dogs with spontaneously occurring malignant tumors.
Ahaus EA; Couto CG; Valerius KD
J Am Anim Hosp Assoc; 2000; 36(5):422-6. PubMed ID: 10997518
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.
Sorenmo KU; Jeglum KA; Helfand SC
J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034
[TBL] [Abstract][Full Text] [Related]
18. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of factors associated with second remission in dogs with lymphoma undergoing retreatment with a cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy protocol: 95 cases (2000-2007).
Flory AB; Rassnick KM; Erb HN; Garrett LD; Northrup NC; Selting KA; Phillips BS; Locke JE; Chretin JD
J Am Vet Med Assoc; 2011 Feb; 238(4):501-6. PubMed ID: 21320021
[TBL] [Abstract][Full Text] [Related]
20. Ventricular fractional shortening in 108 dogs with malignant lymphoma undergoing chemotherapy with a cyclic combination protocol including doxorubicin.
Tater G; Eberle N; Hungerbuehler S; Joetzke A; Nolte I; Wess G; Betz D
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(4):261-6. PubMed ID: 22911257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
